Live mouse mutagenesis systems for testing mutagenic agents in v

Details Live mouse mutagenesis systems for testing mutagenic agents in v Live mouse mutagenesis systems for testing mutagenic agents in v

1995-06-05

2000-04-25

Crouch, Deborah

Multicellular living organisms and unmodified parts thereof and

Nonhuman animal

Transgenic nonhuman animal

800 3, 800 25, 424 92, A01K 67027, A01K 6900, C12N 1500

Patent

active

060546336

ABSTRACT:
Novel transgenic nonhuman animals, such as transgenic mice, for detecting and characterizing mutations in vivo are disclosed. When detecting reverse mutations, such as mutations of the APRT gene, the transgenic nonhuman animal now afford the unique advantage of detecting and characterizing mutations in vivo without having to sacrifice the animals as required heretofore. Moreover, since the transgenic nonhuman animals do not need to be sacrificed, they provide the unique opportunity to correlate the incidence and location of tumors (carcinogenesis) with the incidence and location of mutagenesis. Also disclosed are novel constructs, cell lines and chimeric animals for producing the novel transgenic animals. Novel methods for detecting and characterizing the mutations in vivo and producing animals for use in accordance with the methods of the instant invention are disclosed.

REFERENCES:
patent: 4792520 (1988-12-01), Stambrook et al.
Schaff et al., Proc. Natl. Acad. Sci. 87: 8675-8679 (1990).
Koller et al., Proc. Natl. Acad. Sci. 86: 8932-8935 (1989).
Zijlstra et al., Nature 342: 435-438 (1989).
Mansour et al., GATA 7(8): 219-227 (1990).
Robertson, Biology of Reproduction 44: 238-245 (1991).
Kohler et al., Proc. Natl. Acad. Sci. 88: 7958-7962 (1991).
Hollstein, M. et al.: Mutat. Res., 65:133-226 (1979).
McCann, J. et al.: Proc. Natl. Acad. Sci. USA, 72:5135-5139 (1975).
Ames, B.N. et al.: Science, 176:47-48 91972).
Maron, D.M. et al.: Mut. Res., 113:173-215 (1983).
McCann, J. et al.: Proc. Natl. Acad. Sci. USA, 73:950-954 (1976).
Lu, A.Y.H. et al.: Pharmacol. Rev., 31:277-295 (1980).
Gonzalez, F.J. et al.: Mut. Res., 247:113-127 (1991).
Dush, M.K. et al.: Nucleic Acids Res., 16:8509-8524 (1988).
Doetschman, T.C. et al.: J. Embryol. Exp. Morphol., 87:27-45 (1985).
Martin, G.R. et al.: Proc. Natl. Acad. Sci. USA, 72:1441-1445 (1975).
Williams, R.L. et al.: Nature, 336:684-687 (1988).
Smith, A.G. et al.: Nature, 52:121-131 (1988).
Williams, R.L. et al.: Cell, 52:121-131 (1988).
Schaff, D.A. et al.: Proc. Natl. Acad. Sci. USA, 87:8675-8679 (1990).
Jong, P.J. et al.: Proc. Natl. Acad. Sci. USA, 85:3499-3503 (1988).
Doetschman et al.: Proc. Natl. Acad. Sci. USA, 85:8583-8587 (1988).
Dush, M.K. et al.: Proc Natl. Acad. Sci. USA, 82:2731-2735(1985).
Sikela, J.M. et al.:Gene, 22:219-228 (1983).
Wallace, R.B. et al.:Nucl. Acid. Res., 9:3647-3656 (1981).
Bowman, et al.: Technique-J. Methods & Cell & Molecular Biology, 2:254-260 (1990).
Zarucki-Schultz, T. et al.: J. Biol. Chem., 257:11070-11077 (1982).
Broderick, T.P. et al.: Proc. Natl. Acad. Sci. USA, 84:3349-3353 (1987).
Nesterova, T.B. et al.: Biochem. Gent., 25:563-568 (1987).
Kozak, C.E. et al.: Somat, Cell Genet., 1:371-382 (1975).
Tischfield, J.A. et al.: Mol. Cell. Biol., 2:250-257 (1982).
Miles, C. et al.: Mol. Carcinog., 3:233-242 (1990).
DeBoer, J.G. et al.: Carcinogenesis, 10:1363-1367 (1989).
Singer-Sam, J. et al.: Nucl. Acid. Res., 18:1255-1259 (1990).
Turker, M.S.: Somat. Cell Mol. Genet., 16:331-340 (1990).
Handeli, S. et al.: Cell, 57:909-920 (1989).
Kang, C. Y.: J. Viol., 40:946-952 (1981).
Hooper, M, et al.: Nature, 326:292-295 (1987).
Bertino, A.M. et al.: Mol. Gen. Genet., 232:24-32 (1992).
Kohler S.W. et al.: Proc. Natl. Acad. Sci. USA, 88:7958-7962 (Sep. 1991).
Ponniah, S. et al.: Phenotypic reversion of transgenic mammalian cells designed to detect deletions or rearrangements; Cell Biology (Joint Meeting), Mon. Mutagen. (448-467) p. 83a.
Dush, M.K. et al.: Proc. Natl. Acad. Sci. USA, 82:2731-2735 (May 1985).
Dush, M.K. et al.: Nucleic Acids Research, 16(17):8509-8524 (1988).
Fishbein, L. et al.: Safe Handling of Chemical Carcinogens, Mutagens, Teratogens and Highly-Toxic Substances, vol.1, Ann Arbor, MI: Ann Arbor Science (1980), pp. 329-363.
Dush, M.K. et al.: Proc. Natl. Acad. Sci. USA, 82:2731-2735 (May 1985).
Identifying & Estimating the Genetic Impact of Chemical Mutagens, Nat'l Acad. Press, Washington, D.C. (1983).
Waters, M.D. pp. 449-467 in: A.W. Hsie et al., Eds., Mammalian Cell Mutagenesis: The Maturation of Test Systems, Banbury Report 2. New York: Cold Spring Harbor Laboratory (1979).
Robertson, E.J. in: Teratocarcinomas and Embryonic Stem Cells, A Practical Approach, e.d. Robertson, IRL Press; and Oxford, Washington, D.C., 1987.
Dlouhy, S.R. et al.: Mol. Carcinog., 2:217-225 (1989).
Taylor, M.W. et al.: Adv. Exp. Med. Biol., 253A:467-473 (1989).
Hogan, B. et al. in: Manipulating the Mouse Embryo: A Laboratory Manual, Cold Spring Harbor Laboratory (1986).
Ashby, J. pp. 1-33. Mutagenicity: New Horizons in Toxicology. Ed. J.A. Heddle, NY, Academic Press (1982).
"Mutational analysis of the cloned chicken tymidine kinase gene," Kwoh,et. al., Mol. Appl. Genet., 2(2): 191-200 (1983).
"Molecular cloning and structural analysis of murine thymidine kinase genomic and cDNA sequences," Lin, et al., Mol. Cell Biol., 5(11): 3149-56 (1985).
"Structure and expression of the Chinese hamster thymidine kinase gene," Lewis, Mol. Cell. Biol., 6(6): 1998-2010 (1986).
"The organization of the human HPRT gene," Kim, et al., Nucleic Acids Res. 14(7): 3103-18 (1986).
"Fine structure of the human hypoxanthine phosphoribosyltransferase gene," Patel, et al., Mol. Cell. Biol. 6(2): 393-403 (1986).
Sequence, structure and promoter characterization of the human thymidine kinase gene, Flemington,Gene 52(2-3): 267-77 (1987).
"Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells," Reid, et al., Proc. Natl. Acad. Sci. USA, 87(11): 4299-303 (1990).
"Mutations causing defective splicing in the human HPRT gene," Andersson, et al., Environ. Mol. Mutagen 20(2):89-95 (1992).
"Germ-line transmission of a planned alternation made in a hypoxanthine phosphoribosyltransferase gene by homologogous recombination in embryonic stem cells," Koller, et al., Proc. Natl. Acad. Sci. USA, 86(22): 8927-31 (1989).
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells, Thomas, et al., Cell, 51(3): 503-12 1987).
Kohler et al., 1990 "The use of transgenic mice for short-term, in vivo mutagenicity testing", GATA 7(8):212-218, 1990.

Affiliated with

Also associated with

Rating

Live mouse mutagenesis systems for testing mutagenic agents in v does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Live mouse mutagenesis systems for testing mutagenic agents in v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Live mouse mutagenesis systems for testing mutagenic agents in v will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-994597